INFINITY PHARMACEUTICALS, INC. - FORM 10-K - EX-32.1 - CERTIFICATION OF PEO AND PFO PURSUANT SECTION 906 - March 16, 2011

Attached files

file filename
10-K - FORM 10-K - INFINITY PHARMACEUTICALS, INC.d10k.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - INFINITY PHARMACEUTICALS, INC.dex211.htm
EX-31.1 - CERTIFICATION OF PEO AND PFO PURSUANT SECTION 302 - INFINITY PHARMACEUTICALS, INC.dex311.htm
EX-23.1 - CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - INFINITY PHARMACEUTICALS, INC.dex231.htm

EXHIBIT 32.1

STATEMENT PURSUANT TO 18 U.S.C. §1350

Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Annual Report on Form 10-K for the period ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Infinity Pharmaceuticals, Inc.

 

Dated: March 16, 2011    

/s/    ADELENE Q. PERKINS        

   

Adelene Q. Perkins

President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to Infinity Pharmaceuticals, Inc. and will be retained by Infinity Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

INFINITY PHARMACEUTICALS, INC. Reports